Pierre Ruffiè
Impact in
- Pulmonary and Respiratory Medicine top 0.2%
- Occupational and environmental lung diseases
- Pleural and Pulmonary Diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Medical Imaging and Pathology Studies
- Oncology top 2%
- Lung Cancer Research Studies
Papers in
-
- Occupational and environmental lung diseases 23
- Lung Cancer Treatments and Mutations 18
- Pleural and Pulmonary Diseases 12
- Oncology 30
- Lung Cancer Research Studies 25
- Peptidase Inhibition and Analysis 7
- Cancer Treatment and Pharmacology 6
- Co-authors
- James J. Rusthoven (2 shared papers)Nicholas J. Vogelzang (2 shared papers)Claude Denham (2 shared papers)U. Gatzemeier (2 shared papers)Clet Niyikiza (2 shared papers)Salih Emri (2 shared papers)James T. Symanowski (2 shared papers)Christian Manegold (2 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Lung Cancer (9 papers)European Journal of Cancer (7 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)Annals of Oncology (3 papers)
- Partner nations
- FranceUnited KingdomGermany
In The Last Decade
Pierre Ruffiè
83 papers receiving 4.8k citations
Pierre Ruffiè's Hit Papers
Peers
Comparison fields: 5 of 96
- Pulmonary and Respiratory Medicine 3.2k
- Oncology 1.2k
- Neurology 351
- Biotechnology 179
- Epidemiology 548
Countries citing papers authored by Pierre Ruffiè
This map shows the geographic impact of Pierre Ruffiè's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Ruffiè with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Ruffiè more than expected).
Fields of papers citing papers by Pierre Ruffiè
This network shows the impact of papers produced by Pierre Ruffiè. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Ruffiè. The network helps show where Pierre Ruffiè may publish in the future.
Co-authors
The 25 scholars most cited alongside Pierre Ruffiè, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma Hit paper breakdown → | 2003 | 2304 |
| 2 | 1989 | 274 | |
| 3 | 1991 | 213 | |
| 4 | 1998 | 187 | |
| 5 | 1993 | 183 | |
| 6 | 1996 | 155 | |
| 7 | 1979 | 152 | |
| 8 | 1994 | 111 | |
| 9 | 2003 | 97 | |
| 10 | 2003 | 95 | |
| 11 | 1985 | 81 | |
| 12 | 2001 | 69 | |
| 13 | 2002 | 68 | |
| 14 | 1998 | 60 | |
| 15 | 1996 | 56 | |
| 16 | 2000 | 55 | |
| 17 | 1998 | 54 | |
| 18 | 1992 | 45 | |
| 19 | 1999 | 42 | |
| 20 | 1992 | 41 |
About Pierre Ruffiè
Pierre Ruffiè is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Neurology and Surgery, having authored 88 papers that have together received 4.9k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (25 papers), Occupational and environmental lung diseases (23 papers), Neuroendocrine Tumor Research Advances (20 papers), Lung Cancer Treatments and Mutations (18 papers), Pleural and Pulmonary Diseases (12 papers), Neuroblastoma Research and Treatments (10 papers), Peptidase Inhibition and Analysis (7 papers) and Cancer Treatment and Pharmacology (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.2k citations), Oncology (1.2k citations), Neurology (351 citations), Biotechnology (179 citations) and Epidemiology (548 citations). Pierre Ruffiè has collaborated with scholars based in France, United Kingdom and Germany. Frequent co-authors include James J. Rusthoven, Nicholas J. Vogelzang, Claude Denham, U. Gatzemeier, Clet Niyikiza, Salih Emri, James T. Symanowski, Christian Manegold, Paolo Paoletti and Michael Boyer. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, European Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.